- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neoplasms, Prostate in United Kingdom
Total 49798 results
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis PharmaceuticalsTerminatedProstate Cancer | Castrate Resistant Prostate Cancer | Chemotherapy Naive Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Blue Earth DiagnosticsSyne Qua Non Limited; Innovate UK; IND 2 Results LLCCompletedCancer of the ProstateUnited Kingdom
-
St. Bartholomew's HospitalCompletedProstate CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); AEterna ZentarisCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)UnknownRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
University of California, IrvineWithdrawnProstate LesionsUnited States
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)RecruitingProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | ProstateUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationTerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Hormone-Resistant Prostate CancerUnited States
-
Medical Research CouncilCompletedProstate CancerUnited Kingdom, South Africa
-
University of MiamiNational Cancer Institute (NCI)CompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Northwestern UniversityGenzyme, a Sanofi CompanyWithdrawnPROSTATE CANCERUnited States
-
David M. Schuster, MDTerminatedProstate CancersUnited States
-
BayerActive, not recruitingBone Metastatic Castration-resistant Prostate CancerFrance, Lithuania, Israel, Italy, United Kingdom, Austria
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Neoplasms | Prostate Specific AntigensUnited States
-
University of MiamiWithdrawnProstate Cancer | Prostate AdenocarcinomaUnited States
-
John Chang, MDUnknownProstate AdenocarcinomaUnited States
-
Jeanne LinkOregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...Approved for marketingProstatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterCompletedStage II Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
University of Wisconsin, MadisonProstate Cancer Foundation; Madison Vaccines, IncCompletedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
GenSpera, Inc.WithdrawnProstate Cancer.United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate... and other conditionsUnited States
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingProstate Cancer | Genetic PredispositionUnited Kingdom
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
European Organisation for Research and Treatment...CompletedProstate CancerNetherlands, Belgium, Israel, Malta, Russian Federation, Turkey, United Kingdom
-
Mayo ClinicRecruitingPrimary Malignant Neoplasm of Prostate (Diagnosis)United States
-
University of UtahGenentech, Inc.; Bavarian NordicWithdrawnProstate AdenocarcinomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedEnzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate CancerRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
BioProtectCompletedProstate CancerUnited States, Israel, United Kingdom, Netherlands, Poland, Portugal
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
University of FloridaCompleted
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Baylor College of MedicineCompletedLocalized Prostate CancerUnited States